Literature DB >> 18940285

Relation of left ventricular infarct transmurality and infarct size after primary percutaneous coronary angioplasty to time from symptom onset to balloon inflation.

Joo-Yong Hahn1, Young Bin Song, Hyeon-Cheol Gwon, Yeon Hyeon Choe, Jun Hyung Kim, Jidong Sung, Seung-Hyuk Choi, Jin Ho Choi, Duk Kyung Kim, Kyung Pyo Hong, Jeong Euy Park, Sang Hoon Lee.   

Abstract

This study was performed to evaluate the impact of time to reperfusion on infarct size and transmurality after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). In 73 patients undergoing primary PCI for STEMI, contrast-enhanced magnetic resonance imaging was performed. Infarct size and transmurality on delayed-enhancement imaging were measured. Infarct size was not associated with symptom onset-to-balloon time (23 +/- 9% for <180 minutes, 22 +/- 9% for 180 to 360 minutes, and 24 +/- 11% for >360 minutes, p = 0.62) or door-to-balloon time (23 +/- 8% for <90 minutes, 23 +/- 10% for 90 to 120 minutes, and 22 +/- 11% for >120 minutes, p = 0.88). Infarct transmurality increased significantly with a delay of symptom onset-to-balloon time (73 +/- 22% for <180 minutes, 78 +/- 14% for 180 to 360 minutes, and 86 +/- 14% for >360 minutes, p = 0.04), but not for door-to-balloon time (79 +/- 15% for <90 minutes, 76 +/- 19% for 90 to 120 minutes, and 81 +/- 18% for >120 minutes, p = 0.62). In multivariate analysis, anterior infarction (odds ratio 4.15, 95% confidence interval 1.31 to 13.18, p = 0.02) and myocardial blush grade 0/1 (odds ratio [OR] 3.89, 95% confidence interval [CI] 1.13 to 13.51, p = 0.03) independently predicted a large infarct (infarct size > or =25%). Symptom onset-to-balloon time (OR per 30 minutes 1.26, 95% CI 1.04 to 1.53, p = 0.02) was an independent predictor of transmural infarct (average transmural extent > or =75%) and use of glycoprotein IIb/IIIa inhibitors showed a protective effect (OR 0.09, 95% CI 0.02 to 0.53, p = 0.007). In conclusion, symptom onset-to-balloon time was significantly associated with infarct transmurality but not infarct size in patients undergoing primary PCI for STEMI.

Entities:  

Mesh:

Year:  2008        PMID: 18940285     DOI: 10.1016/j.amjcard.2008.06.042

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Time-dependency, predictors and clinical impact of infarct transmurality assessed by magnetic resonance imaging in patients with ST-elevation myocardial infarction reperfused by primary coronary percutaneous intervention.

Authors:  Suzanne de Waha; Ingo Eitel; Steffen Desch; Georg Fuernau; Philipp Lurz; Deniz Haznedar; Matthias Grothoff; Matthias Gutberlet; Gerhard Schuler; Holger Thiele
Journal:  Clin Res Cardiol       Date:  2011-11-10       Impact factor: 5.460

2.  The REFLO-STEMI trial comparing intracoronary adenosine, sodium nitroprusside and standard therapy for the attenuation of infarct size and microvascular obstruction during primary percutaneous coronary intervention: study protocol for a randomised controlled trial.

Authors:  Sheraz A Nazir; Jamal N Khan; Islam Z Mahmoud; John P Greenwood; Daniel J Blackman; Vijay Kunadian; Martin Been; Keith R Abrams; Robert Wilcox; A A Jennifer Adgey; Gerry P McCann; Anthony H Gershlick
Journal:  Trials       Date:  2014-09-25       Impact factor: 2.279

3.  Symptom-to-balloon time and myocardial blush grade are predictors of left ventricular remodelling after successful primary percutaneous coronary intervention.

Authors:  El-Sayed M Farag; Mohammad M Al-Daydamony
Journal:  Cardiovasc J Afr       Date:  2016-10-21       Impact factor: 1.167

4.  The Impact of COVID-19 on Lombardy Region ST-Elevation Myocardial Infarction Emergency Medical System Network-A Three-Year Study.

Authors:  Giuseppe Stirparo; Lorenzo Bellini; Giuseppe Ristagno; Rodolfo Bonora; Andrea Pagliosa; Maurizio Migliari; Aida Andreassi; Carlo Signorelli; Giuseppe M Sechi; Nazzareno Fagoni
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

5.  Delay from first medical contact to primary PCI and all-cause mortality: a nationwide study of patients with ST-elevation myocardial infarction.

Authors:  Sasha Koul; Pontus Andell; Andreas Martinsson; J Gustav Smith; Jesper van der Pals; Fredrik Scherstén; Tomas Jernberg; Bo Lagerqvist; David Erlinge
Journal:  J Am Heart Assoc       Date:  2014-03-04       Impact factor: 5.501

6.  D-Dimer Levels Predict Myocardial Injury in ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study.

Authors:  Soonuk Choi; Woo Jin Jang; Young Bin Song; Joao A C Lima; Eliseo Guallar; Yeon Hyeon Choe; Jin Kyung Hwang; Eun Kyoung Kim; Jeong Hoon Yang; Joo-Yong Hahn; Seung-Hyuk Choi; Sang-Chol Lee; Sang Hoon Lee; Hyeon-Cheol Gwon
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

7.  Occurrence and Impact of Time Delay to Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Mohammady Shahin; Slayman Obeid; Lotfy Hamed; Christian Templin; Oliver Gamperli; Fabian Nietlispach; Willbald Maier; Nooraldaem Yousif; Francois Mach; Marco Roffi; Stephan Windecker; Lorenz Raber; Christian M Matter; Thomas F Luscher
Journal:  Cardiol Res       Date:  2017-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.